Your browser doesn't support javascript.
loading
Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial.
Tay, R Y; Fernández-Gutiérrez, F; Foy, V; Burns, K; Pierce, J; Morris, K; Priest, L; Tugwood, J; Ashcroft, L; Lindsay, C R; Faivre-Finn, C; Dive, C; Blackhall, F.
Afiliação
  • Tay RY; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester.
  • Fernández-Gutiérrez F; Clinical and Experimental Pharmacology Group, CRUK Manchester Institute.
  • Foy V; Clinical and Experimental Pharmacology Group, CRUK Manchester Institute.
  • Burns K; Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health.
  • Pierce J; Clinical and Experimental Pharmacology Group, CRUK Manchester Institute.
  • Morris K; Clinical and Experimental Pharmacology Group, CRUK Manchester Institute.
  • Priest L; Clinical and Experimental Pharmacology Group, CRUK Manchester Institute.
  • Tugwood J; Cancer Research UK Manchester Institute; Manchester Centre for Cancer Biomarker Sciences, University of Manchester, Manchester.
  • Ashcroft L; Manchester Academic Health Science Centre Trials Co-ordination Unit.
  • Lindsay CR; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester; Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health.
  • Faivre-Finn C; Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health; Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK.
  • Dive C; Cancer Research UK Manchester Institute; Manchester Centre for Cancer Biomarker Sciences, University of Manchester, Manchester.
  • Blackhall F; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester; Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health. Electronic address: fiona.blackhall@christie.nhs.uk.
Ann Oncol ; 30(7): 1114-1120, 2019 07 01.
Article em En | MEDLINE | ID: mdl-31020334
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares / Células Neoplásicas Circulantes Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares / Células Neoplásicas Circulantes Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article